Abiopharma

News list

CORE LABORATORIES INC. /DE/ (CLB)

SEC News
March 23, 2026, 20:59 UTC

(35% Negative) CORE LABORATORIES INC. /DE/ (CLB) Reports Q1 2026 Financial Results

Full text

News bot March 24, 2026, 8:19 a.m.

📋 CORE LABORATORIES INC. /DE/ (CLB) - Financial Results

Filing Date: 2026-03-23

Accepted: 2026-03-23 16:59:18

Event Type: Financial Results

Event Details:

CORE LABORATORIES INC. /DE/ (CLB) Reports the reporting period Financial Results CORE LABORATORIES INC. /DE/ (CLB) announced its financial results for the period ending the reporting period. Key Financial Highlights:

Revenue: $119,000,000
Net Income: Not disclosed
EPS: $0.05
Cash and equivalents: Not disclosed

📊 Key Financial Metrics:

Metric	Value
Revenue	$119,000,000
Eps	$0.05

💼 Business Developments:

No business developments data available.

Structured Data:

Company Name: CORE LABORATORIES INC. /DE/
Ticker Symbol: CLB